Sources and Turnover Rates of Taurine in Newborn, Weanling, and Mature Rats
The pharmacology of taurine has received close study, and taurine has been shown to be beneficial in conditions as diverse as genetic cardiomyopathy (1), cardiac arrhythmias (2), and epilepsy (5). Deficiencies in taurine have also been associated with the development of such pathological processes as retinal degeneration in cats (9) and cardiomyopathy in humans (4). These investigations have linked taurine with various phenomena without yielding insight into the mechanism by which taurine is acting, or its normal functional involvement in cellular processes.
KeywordsTaurine Level Taurine Concentration Taurine Content Cysteine Sulfinate Decarboxylase Cysteine Sulfinate
Unable to display preview. Download preview PDF.
- 5.Huxtable, R., and Laird, H., 1978, The prolonged anticonvulsant action of taurine on genetically determined seizure susceptibility, Can. J. Neurol. Sci, 5: 215–221.Google Scholar
- 6.Kaczmarek, L.K., A comparison of the evidence for taurine and GABA as neurotransmitters, in: “Taurine,” R. Huxtable and A. Barbeau, eds., Raven Press, New York (1976), pp. 283–292Google Scholar
- 8.National Academy of Sciences: Nutrient Requirements of Domestic Animals, Washington, D.C., (1978).Google Scholar
- 10.Sturman, J.A., 1973, Taurine pool sizes in the rat: Effects of vitamin B-6 deficiency and high taurine diet, J. Nutrition, 103 (11): 1566–1580.Google Scholar